PharmaSynergyRx
February 5-6, 2026
London, UK
https://pharma-synergy-conference.com/pharmasynergy-2026/
News and Events
Subscribe to our press distribution list to receive the latest news about AMW.
Downloads
Upcoming
Events
EuroPLX
March 2-3, 2026
Lisbon, Portugal
https://www.raucon.com/euro-plx/euro-p-l-x-90
EAU Congress
March 13-16, 2026
London, UK
https://eaucongress.uroweb.org/
BIO-Europe Spring
March 23-25, 2026
Lisbon, Portugal
https://informaconnect.com/bioeurope-spring/
CPHI South East Asia
July 8-10, 2026
Bangkok, Thailand
https://www.cphi.com/sea/en/attend/attend/why-attend.html
CPHI Milan
October 6-8, 2026
Milan, Italy
https://www.cphi.com/europe/en/exhibit/book-your-stand-milan.html
Past
Events
Archive
DCAT Week 2025
March 17-20, 2025
New York City, USA
https://dcatweek.org/
AT Uro Congress
May 22-24, 2025
Vienna, Austria
International Partnering in Life-Sciences Society (IPLS)
September 29 – October 1, 2025
Berlin, Germany
https://ipls.online/events/
PODD – Partnership Opportunities in Drug Delivery
October 27-28, 2025
Boston, US
https://poddconference.com/
CPHI Frankfurt
October 28-30, 2025
Frankfurt, Germany
https://www.cphi.com/europe/en/home.html
BIO-Europe
November 3-5, 2025
Vienna, Austria
https://informaconnect.com/bioeurope/
Latest
News
AMW Strengthens Executive Leadership Team by Appointing Wolfram E. Scholl as Chief Operating Officer
Warngau, Germany, September 2, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today announced the appointment of Wolfram E. Scholl as Chief Operating Officer (COO) as of September 1, 2025. As long-standing expert and consultant in supply chain management, he is responsible for production, quality, supply chain, engineering and […]
read moreAMW Secures Successful Long-term Growth Financing from Raiffeisenlandesbank Oberösterreich
Warngau, Germany, July 24, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today announced the closing of a significant financing agreement. This long-term and attractive financing from Raiffeisenlandesbank Oberösterreich allowed the Company to optimize its financing structure and to gain access to an additional line of credit. “With another […]
read moreAMW and AdhexPharma Successfully Complete Strategic Transfer of Transdermal Delivery Systems
Warngau, Germany, Chenôve, France, May 27, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, and AdhexPharma SAS, an independent pharmaceutical company specializing in the development and manufacturing of patches and oral films, today announced the successful completion of the transfer of transdermal delivery systems (TDS) under the companies’ strategic […]
read moreAMW Reports Another Record Result for the 2024 Financial Year
Warngau, Germany, May 13, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today reported financial results for the year ended December 31, 2024. AMW posted another consolidated record revenue for 2024 of EUR 38.2 million, an increase of 30% compared to the previous year (2023: EUR 29.4 million). The […]
read moreAMW Pioneers Use of Artificial Intelligence in Formulation Development
Warngau, February 25, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today announced the launch of a research and development project to optimize formulation development using artificial intelligence (AI). The working group of Prof. Dr. Olivia Merkel, Chair of Drug Delivery at the Department of Pharmacy at Ludwig-Maximilians-Universität (LMU) […]
read more